Craft

Advicenne

Stock Price

€5.2

2022-05-27

Market Capitalization

€64.5 M

2022-05-27

Revenue

€6 M

FY, 2025

Advicenne Summary

Company Summary

Overview
Advicenne is a biopharmaceutical company focused on the development of paediatric friendly therapeutics for the treatment of orphan renal diseases and niche neurology indications.The Company's goal is to improve the lives of patients from early childhood through adulthood by leveraging pharmaceutical and clinical development expertise to develop pediatric friendly therapeutics that answer critical unmet medical needs in the field of rare and neglected diseases.
Type
Public
Status
Active
Founded
2007
HQ
Nîmes, FR | view all locations
Website
https://advicenne.com/
Cybersecurity rating
Sectors

Key People

  • Didier Laurens

    Didier Laurens, Chief Executive Officer, Director

    • André Ulmann

      André Ulmann, Medical Director

      LocationsView all

      3 locations detected

      • Nîmes, Occitanie HQ

        France

        2 Rue Briçonnet

      • Montbonnot-Saint-Martin, Auvergne-Rhône-Alpes

        France

        445 Rue Lavoisier

      • Paris, IDF

        France

        22 Rue de la Paix 3ème étage

      Advicenne Financials

      Summary Financials

      Revenue (FY, 2025)
      €6.0M
      Gross profit (FY, 2025)
      €5.2M
      Net income (FY, 2025)
      (€9.5M)
      Cash (FY, 2025)
      €1.3M
      EBIT (FY, 2025)
      (€8.0M)
      Enterprise value
      $82.2M

      Footer menu